They tackled chronic cough. Now with $54.5 million, this duo is targeting Alzheimer's and more

The team behind CuraSen sold their previous drug development company for up to $1.25 billion.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news